Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Apple
AAPL
|
+$564M |
| 2 |
UnitedHealth
UNH
|
+$439M |
| 3 |
Johnson & Johnson
JNJ
|
+$353M |
| 4 |
Amazon
AMZN
|
+$200M |
| 5 |
Microsoft
MSFT
|
+$198M |
Top Sells
| 1 |
EXE
Expand Energy Corporation Common Stock
EXE
|
+$344M |
| 2 |
JPMorgan Chase
JPM
|
+$293M |
| 3 |
Kellanova
K
|
+$165M |
| 4 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$159M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$156M |
Sector Composition
| 1 | Technology | 18.85% |
| 2 | Financials | 18.69% |
| 3 | Industrials | 11.91% |
| 4 | Healthcare | 10.42% |
| 5 | Consumer Discretionary | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVBN
2376
DELISTED
Evans Bancorp Inc
EVBN
| $7.27M | ﹤0.01% |
186,646
+13,412
| +8% | +$523K |
|
2377
Xenon Pharmaceuticals
XENE
$2.84B
| $7.21M | ﹤0.01% |
214,860
-45,110
| -17% | -$1.51M |
|
|
BFS
2378
Saul Centers
BFS
$785M
| $7.19M | ﹤0.01% |
199,469
+1,731
| +0.9% | +$62.4K |
|
2379
MVB Financial
MVBF
$307M
| $7.19M | ﹤0.01% |
414,881
+25,891
| +7% | +$448K |
|
2380
Virco
VIRC
$128M
| $7.18M | ﹤0.01% |
759,064
+74,686
| +11% | +$707K |
|
2381
Kewaunee Scientific
KEQU
$125M
| $7.18M | ﹤0.01% |
182,220
-2,422
| -1% | -$95.4K |
|
2382
Gambling.com
GAMB
$287M
| $7.16M | ﹤0.01% |
567,017
+63,591
| +13% | +$803K |
|
2383
SEACOR Marine Holdings
SMHI
$174M
| $7.15M | ﹤0.01% |
1,412,432
+7,521
| +0.5% | +$38.1K |
|
2384
Escalade
ESCA
$173M
| $7.14M | ﹤0.01% |
466,971
+10,260
| +2% | +$157K |
|
2385
Provident Financial
PROV
$102M
| $7.12M | ﹤0.01% |
488,274
+1,978
| +0.4% | +$28.9K |
|
2386
National Research Corp
NRC
$369M
| $7.09M | ﹤0.01% |
554,287
-28,192
| -5% | -$361K |
|
|
ITOS
2387
DELISTED
iTeos Therapeutics
ITOS
| $7.05M | ﹤0.01% |
1,181,254
-28,826
| -2% | -$172K |
|
2388
Lifeway Foods
LWAY
$502M
| $7.03M | ﹤0.01% |
287,696
-14,870
| -5% | -$364K |
|
|
GMRE
2389
Global Medical REIT
GMRE
$512M
| $7.02M | ﹤0.01% |
802,011
-43,518
| -5% | -$381K |
|
2390
McEwen Inc.
MUX
$740M
| $7.01M | ﹤0.01% |
928,798
+372,080
| +67% | +$2.81M |
|
2391
Hippo Holdings
HIPO
$931M
| $6.98M | ﹤0.01% |
273,066
+44,929
| +20% | +$1.15M |
|
2392
Disc Medicine
IRON
$2.08B
| $6.92M | ﹤0.01% |
139,393
-327
| -0.2% | -$16.2K |
|
|
ALX
2393
Alexander's
ALX
$1.25B
| $6.91M | ﹤0.01% |
33,052
+283
| +0.9% | +$59.2K |
|
2394
Acme United Corp
ACU
$162M
| $6.91M | ﹤0.01% |
174,338
-3,230
| -2% | -$128K |
|
2395
New Fortress Energy
NFE
$376M
| $6.89M | ﹤0.01% |
828,737
+36,344
| +5% | +$302K |
|
|
ALEX
2396
Alexander & Baldwin
ALEX
$1.35B
| $6.87M | ﹤0.01% |
398,689
+105,611
| +36% | +$1.82M |
|
2397
Cerence
CRNC
$427M
| $6.85M | ﹤0.01% |
867,514
-1,805
| -0.2% | -$14.3K |
|
2398
Accel Entertainment
ACEL
$947M
| $6.84M | ﹤0.01% |
689,262
-911
| -0.1% | -$9.04K |
|
2399
Nurix Therapeutics
NRIX
$691M
| $6.84M | ﹤0.01% |
575,312
+68,473
| +14% | +$814K |
|
2400
NVE Corp
NVEC
$324M
| $6.81M | ﹤0.01% |
106,787
-10,731
| -9% | -$684K |
|